Lexaria to Receive Third Patent Granted in Japan, Submits FDA Filing
MarketScreener,
KELOWNA - (Nasdaq: LEXX) (Nasdaq: LEXXW) (the 'Company' or ''), a global innovator in drug delivery platforms is pleased to…
KELOWNA - (Nasdaq: LEXX) (Nasdaq: LEXXW) (the 'Company' or ''), a global innovator in drug delivery platforms is pleased to…
KELOWNA, BC / ACCESSWIRE / July 14, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a…
(via TheNewswire) Kelowna, British Columbia - TheNewswire - July 14, 2022 - Lexaria Bioscience Corp.